Diabetic Neuropathy: Symptoms, Foot Care and Rehabilitation

Diabetic neuropathy is nerve damage that develops in people with diabetes. It most often affects the longest nerves first, causing numbness, tingling, burning pain or loss of feeling in the toes and feet, and it can later spread to the legs and hands. Walking, balance, sleep and foot safety can all be affected (Pop-Busui et al., 2017; Feldman et al., 2019).

The featured image and supporting patient illustrations are AI-generated and do not depict actual patients.

It usually develops gradually over years, and in the early stages it may cause no symptoms at all. The encouraging news is that, with early screening, steady control of blood glucose and other health risks, careful foot care and individualized rehabilitation, further damage can often be slowed and symptoms can be managed effectively (ADA Standards of Care 2026; Pop-Busui et al., 2017).

What Is Diabetic Neuropathy?

The peripheral nerves carry sensation from the skin, joints and muscles to the spinal cord and brain, and carry movement and automatic (autonomic) signals back to the body. In diabetes, long-standing high blood glucose together with other metabolic and vascular factors injures nerve fibres and the small blood vessels that supply them. Many processes are thought to contribute, including glycation, lipoxidation, inflammation and programmed cell death (apoptosis) inside nerve cells (ADA Standards of Care 2026; Feldman et al., 2019).

The most common form is distal symmetric polyneuropathy, also called diabetic peripheral neuropathy (DPN). The longest nerves, those to the toes and feet, are affected first and on both sides, producing a “stocking” pattern that may later extend to the hands as a “glove” pattern. Small nerve fibres carry pain and temperature, so their involvement causes burning pain and tingling, while large fibres carry touch, vibration and position sense, so their involvement causes numbness, unsteadiness and loss of protective sensation (ADA Standards of Care 2026; Feldman et al., 2019).

Other forms exist, including autonomic neuropathy (affecting the heart, digestion, bladder, sweating and sexual function) and focal neuropathies that affect a single nerve. Importantly, diabetic neuropathy is a diagnosis of exclusion: other, sometimes treatable, causes of nerve damage can be present in a person with diabetes and need to be ruled out (Pop-Busui et al., 2017; ADA Standards of Care 2026).

How Common Is It? Prevalence and Epidemiology

There is no single worldwide prevalence estimate for diabetic neuropathy because definitions and tests differ. NIDDK estimates that peripheral neuropathy affects about one-third to one-half of people with diabetes. The IDF Diabetes Atlas estimated 589 million adults aged 20–79 living with diabetes in 2024; that is a diabetes estimate, not a count of neuropathy cases (IDF Diabetes Atlas 2025).

A study of type 2 diabetes outpatients in Bangladesh reported diabetic peripheral neuropathy in 19.7% of the clinic sample. This single-clinic result does not represent the whole country. Age, duration of diabetes, assessment method and other health factors influence observed prevalence (Mørkrid et al., 2010).

Studies of painful neuropathy, all peripheral neuropathy and different clinic populations measure different outcomes. Their percentages should not be treated as a direct comparison or used to predict one person’s risk. A systematic review specifically examined painful diabetic neuropathy and found substantial variation between studies and diagnostic methods (Tao et al., 2025).

Causes and Risk Factors

The underlying cause is long-standing diabetes, but not everyone with diabetes develops neuropathy. It is best understood as multifactorial, shaped by blood glucose control, duration of diabetes, vascular and metabolic risk factors and other health conditions (Tesfaye et al., 2005; ADA Standards of Care 2026).

• Long-term glucose exposure and duration of diabetes are important risk factors. In the EURODIAB prospective study, neuropathy incidence was associated with HbA1c and diabetes duration; cardiovascular risk factors also mattered. Associations do not identify the cause of every individual patient’s symptoms (Tesfaye et al., 2005).
• Cardiovascular and metabolic risk factors: higher triglycerides, higher body-mass index, smoking and hypertension were associated with a higher incidence of neuropathy in EURODIAB, over and above glycemic control. Obesity and dyslipidemia are also linked to neuropathy in type 2 diabetes (Tesfaye et al., 2005; ADA Standards of Care 2026).
• Age, treatment and socioeconomic factors: in the Dhaka study, higher age, low socioeconomic status and insulin treatment (which may be a marker of longer or more advanced diabetes) were significant risk factors (Mørkrid et al., 2010).
• Vitamin B12 deficiency and metformin: long-term metformin use has been associated with biochemical vitamin B12 deficiency, and in one large follow-up study neuropathy was more common in metformin-treated participants with low B12. Because B12 deficiency can cause or worsen neuropathy, it is worth checking (Aroda et al., 2016; ADA Standards of Care 2026).
• Other causes that can coexist or mimic: alcohol, neurotoxic medicines such as some chemotherapy, other nutritional deficiencies, hypothyroidism, kidney disease, certain infections and cancers, and inflammatory or inherited neuropathies (ADA Standards of Care 2026).
• Other diabetes complications: co-existing nephropathy was associated with higher odds of painful DPN in a meta-analysis (Tao et al., 2025).

Not everyone with these risk factors develops neuropathy, and glucose control reduces risk but does not remove it entirely. Still, people with long-standing diabetes, poor glucose control, several vascular risk factors or a known deficiency deserve regular screening and closer assessment when numbness, tingling or pain appear (ADA Standards of Care 2026; Pop-Busui et al., 2017).

Symptoms and Pain Location

Symptoms depend on which fibres are affected, and many people have none, which is why routine screening matters. Consider professional assessment if you notice: (Pop-Busui et al., 2017; ADA Standards of Care 2026).

• Tingling, pins-and-needles or burning sensations in the toes and feet
• Numbness or reduced feeling, such as not noticing a cut, blister or hot water on the feet
• Sharp, shooting or electric-shock pain, often worse at night
• Pain from light contact, such as socks, shoes or bedclothes (allodynia)
• Unsteadiness, loss of balance or falls
• Weakness of the foot and ankle muscles, or a change in foot shape in more advanced cases

Pain and abnormal sensation usually begin in the toes and soles and spread upward on both sides in a stocking pattern, sometimes reaching the hands later. Neuropathic pain can be severe and can affect sleep, mobility and mood (ADA Standards of Care 2026; Pop-Busui et al., 2017). When autonomic nerves are involved, people may also notice dizziness on standing, a fast resting heart rate, constipation or diarrhea, bladder problems, changes in sweating, dry cracked skin or erectile dysfunction (ADA Standards of Care 2026).

Foot warning: never ignore a wound, blister, swelling, redness or warmth on a numb foot. Because pain sensation is reduced, an ulcer or infection can progress without much pain. Seek medical care the same day for an open sore, spreading redness, discharge, fever, or a warm, swollen, red foot, which may signal infection or Charcot neuroarthropathy (ADA Standards of Care 2026; Armstrong et al., 2017).

Does it only affect the feet? Not always. Distal symmetric neuropathy usually starts in the feet, but diabetes can also affect the autonomic nerves and individual nerves. Sudden or rapidly progressive symptoms, symptoms on one side only, or prominent weakness are atypical and should be assessed promptly by a physician (ADA Standards of Care 2026; Pop-Busui et al., 2017).

The Three Stages and Recovery Time

Diabetic neuropathy is better described as a spectrum than as sharply separated stages, but it can be helpful to think in three broad phases (Pop-Busui et al., 2017; Feldman et al., 2019).

• Stage 1: Early Stage

nerve damage has begun, but there may be no symptoms or only mild tingling, and reduced vibration or temperature sensation may be found on examination. This can persist for years and is the best window for prevention through glucose and risk-factor control and foot-care education (ADA Standards of Care 2026; Pop-Busui et al., 2017).

• Stage 2: Symptomatic Stage

burning, tingling or shooting pain and sensory changes become noticeable, usually in a stocking pattern, and sleep, balance and daily activities can be affected. Pain can often be reduced with appropriate treatment (ADA Standards of Care 2026; Pop-Busui et al., 2017).

• Stage 3: Advanced Stage

sensation is substantially reduced. Pain may be less prominent in some people, but loss of protective sensation makes injuries easy to miss and raises the risk of foot deformity, ulcers, infection and amputation. The priority is protection and regular surveillance of the feet (ADA Standards of Care 2026; Armstrong et al., 2017).

Recovery depends on the neuropathy type and cause. Established nerve loss may persist, so care emphasizes prevention or slowing of progression, symptom treatment and protection from injury. A healed diabetic foot ulcer can recur; ongoing footwear, skin checks and professional foot-risk assessment remain important. Other contributors, including vitamin B12 deficiency, should be considered when clinically indicated (ADA Standards of Care 2026; Armstrong et al., 2017).

Assessment and Treatment: Structural Diagnosis and Management (SDM) at ASPC Manipulation Therapy

How SDM assesses a person with suspected diabetic neuropathy

Published descriptions present SDM as a comprehensive, systematic approach: a detailed history, examination of joint motion (arthrokinematic and osteokinematic), stretching and length assessment of muscle chains with a biomechanical rationale, strength testing of prime movers and segmental or regional stabilizers, and neurological examination, all combined to reach a structural diagnosis that directs conservative management. Applied to a person with diabetes and suspected neuropathy, this means: (Haque et al., 2020; ADA Standards of Care 2026).

• History and staging: identifying the symptom pattern (burning, numbness, night pain, balance problems), duration of diabetes, recent HbA1c, medicines such as metformin, alcohol use and previous foot ulcers, and recognizing whether the picture is early, symptomatic or advanced (ADA Standards of Care 2026).
• Sensory and neurological examination: guideline-recommended screening includes pinprick or temperature sensation, vibration testing with a 128-Hz tuning fork and 10-g monofilament testing for loss of protective sensation, at least annually (ADA Standards of Care 2026).
• Structural examination: assessing the spine, hip, knee, ankle and foot joints, muscle length and strength, gait and balance, because mechanical problems can coexist with, or imitate, neuropathy, and balance problems and foot deformity increase the risk of falls and ulcers (ADA Standards of Care 2026; Armstrong et al., 2017).
• Differential diagnosis and referral: distinguishing diabetic neuropathy from nerve-root, vitamin B12, thyroid, kidney, alcohol-related, medicine-related and other causes. Sudden onset, asymmetry or prominent weakness prompt physician or neurologist review, and an open wound, signs of infection or a hot swollen foot prompt urgent referral to a foot-care team (ADA Standards of Care 2026).

How SDM guides management

• Diagnosis-led plan: care is chosen from the structural and neurological findings and matched to the stage, rather than applying one fixed protocol to every person.
• Manual and manipulation therapy, adapted for numb areas: ASPC delivers SDM-guided care primarily through hands-on manual and manipulation-based therapy, supported by patient education and functional rehabilitation. In diabetic neuropathy this is directed at coexisting joint and muscle problems and function, not at reversing nerve damage, with extra care for numb skin that is easily injured (ADA Standards of Care 2026).
• Exercise, balance and gait training: two systematic reviews found that exercise improved neuropathy outcomes, including symptoms, examination findings, balance and function, although the strength of the evidence is low (ADA Standards of Care 2026).
• Foot protection and education: daily foot inspection, well-fitting footwear, no walking barefoot, and prompt treatment of any lesion, with referral to a foot-care specialist when risk is moderate or high (Bus et al., 2024; Schaper et al., 2024).
• Regular reassessment: the structural and neurological examination is repeated so the plan can change as symptoms and function change.
• Medical co-management includes glucose, blood pressure, lipids and other relevant risks. For painful diabetic neuropathy, a prescriber may consider medicines from several recommended classes after reviewing other conditions, interactions and adverse effects. Opioids are generally avoided. Do not select or change medicines without the treating clinician (ADA Standards of Care 2026).
• Medical and surgical options when needed: topical treatments such as capsaicin or lidocaine, and, for foot ulcers, offloading, debridement, treatment of infection or poor circulation, and surgery for deformity, are decisions for a physician or interprofessional foot team (ADA Standards of Care 2026).

Evidence context: SDM has a published description concerning lumbar mechanical dysfunction and a journal-published trial concerning plantar heel pain. These are different study designs and clinical populations. They do not establish that SDM is superior or effective for every presentation of diabetic neuropathy. Care should follow the diagnosis, relevant guidance and measured progress; medical referral takes priority when indicated.

Nutrition and Daily Tips

Nutrition supports glucose management, cardiovascular health and rehabilitation; no food or supplement is an established cure for diabetic neuropathy. Choose an individualized balanced diet, avoid excess alcohol and discuss vitamin B12 testing when relevant, including during long-term metformin use. Dietary trials should not be interpreted as proof of reversal of established nerve injury (Aroda et al., 2016; ADA Standards of Care 2026).

Also check your feet every day (using a mirror or help from a family member), moisturize dry skin, avoid cutting calluses or ingrown nails yourself, never walk barefoot, wear well-fitting shoes, have a full foot examination at least once a year (more often if sensation is reduced), keep active within a comfortable range, stop smoking, and take your diabetes medicines as prescribed (ADA Standards of Care 2026; Bus et al., 2024).

Other Conditions and When to Get Help

Not every numb or painful foot in a person with diabetes is diabetic neuropathy. Vitamin B12 deficiency, hypothyroidism, kidney disease, alcohol-related or medicine-related neuropathy, spinal nerve-root problems and inflammatory or inherited neuropathies can look similar or coexist, and poor circulation from peripheral artery disease can add to leg pain and slow healing, which is why clinical assessment matters. See a doctor or physiotherapist if: (ADA Standards of Care 2026; Pop-Busui et al., 2017).

• Numbness, tingling or burning pain persists, spreads or worsens
• You cannot feel your feet well, or have not had a foot and sensation check in the past year
• Night pain significantly disturbs sleep, or you are losing balance or falling
• Symptoms began suddenly, affect one side only, or come with new weakness
• You notice a blister, sore, swelling, redness or warmth on a foot (seek same-day care)
• Self-care at home is not helping
• You have unexplained chest pain, breathlessness or fainting (seek urgent care)

Final Takeaway

Diabetic neuropathy is more than ordinary foot or leg discomfort: it combines altered sensation, pain, weakness and balance problems that can silently put the feet at risk of ulcers and serious infection. Outcomes are usually best served by early screening, steady control of glucose and other vascular risk factors, daily foot protection, pain treatment chosen with a physician, and gradual, supervised rehabilitation, rather than waiting for symptoms to become severe. The Structural Diagnosis and Management (SDM) approach practiced at ASPC Manipulation Therapy offers one diagnosis-led pathway for the structural and functional side of care, alongside medical management. If you have diabetes and notice numbness, tingling, burning pain, balance problems or any foot wound, seek assessment from a qualified healthcare professional. The goal is not just less pain, but protected feet, steadier movement, better sleep and confidence in everyday life (ADA Standards of Care 2026; Pop-Busui et al., 2017).